I've heard from a friend that runs a pharmacy that Biome is his most profitable product and it sits front and centre.
Good sales momentum - organic grown and new products, growing market share locally & overseas, excellent distribution channel and positive free cash flow a reality ... yet de-rate continues. Too may people who got seed still bailing out ... but once this is all out, then we should expect fundamentals to shine through.
Ann: Quarterly Activities & Cashflow Report, page-4
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.0¢ |
Change
0.055(9.57%) |
Mkt cap ! $135.5M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 63.0¢ | 59.5¢ | $809.2K | 1.316M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2050 | 62.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 90929 | 5 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BIO (ASX) Chart |